Life Science News and Press Releases

Short Guide to 3D Cell Culture

AMS Biotechnology (AMSBIO)

26/03/2013

A new informative booklet entitled ‘Short Guide to 3D Cell Culture’ has been produced by AMSBIO. Drawing upon a wealth of experience of working with a wide range of 3D cell culture procedures and formats the guide is aimed at assisting research scientists looking to culture cells in more physiologically relevant environments.Traditional monolayer cell culture on plastic dishes or in flasks, rarely recreates the conditions cells experience in vivo. Over the past...

Fast Acting Arthritogenic Monoclonal Antibody Cocktails

AMS Biotechnology (AMSBIO)

28/02/2013

AMSBIO has announced a new 5-Clone Collagen Antibody-Induced Arthritis (CIAA) kit for the induction of Collagen-Induced Arthritis (CIA) in various species.Collagen Antibody-Induced Arthritis (CAIA) has been widely used since 1998 when 4-clone cocktail (Arthrogen-CIA® arthritogenic monoclonal antibodies) kits first appeared. In order to induce consistent arthritis more effectively in various mouse strains including CAIA low responder C57BL/6 mice, and a variety of...

Highly Purified Chondroitinase ABC for Neural Regeneration Research

AMS Biotechnology (AMSBIO)

21/02/2013

AMSBIO, a specialist supplier of high purity reagents for glycobiology and regenerative medicine, has announced the launch of a new, highly purified Chondroitinase ABC. This new enzyme is supplied protease-free, carrier-free and with low-endotoxin levels for use in neuroscience and regenerative medicine research.Chondroitin Sulfate Proteoglycans (CSPGs) are involved in the inhibition of axon regeneration after various forms of damage to the Central Nervous System,...

New Opportunities in Cancer Research Created By Extracellular Matrix

AMS Biotechnology (AMSBIO)

08/02/2013

A new white paper, available from AMSBIO, discusses the latest developments in extracellular matrix (ECM) and the opportunities they offer in cancer research.At least 80% of cancers are carcinomas, or tumours of the epithelia. Traditionally, cell transformation to a cancerous stage has been evaluated by anchorage dependent growth. More recently, the role of the extracellular matrix, already established in normal epithelial biology, has come to the fore in the study of...

Purified Genomic DNA and cDNA Products Save Research Time

AMS Biotechnology (AMSBIO)

22/01/2013

Drawing upon 25 years experience of serving life science research laboratories - AMSBIO has put together a comprehensive range of genomic DNA and cDNA products derived from various human normal and disease state tissue types. These purified samples save valuable research time allowing the immediate identification of genes of interest without the need to acquire tissues and perform in-house processing.AMSBIO has added cancer and normal tissue cDNA arrays to its cDNA range...

Integrating matrix into 3D spheroid culture enables high throughput measurement of cell invasion

AMS Biotechnology (AMSBIO)

21/12/2012

AMSBIO has announced the launch of the 3D Culture 96-Well BME* Cell Invasion Assay to address the growing need for more complete and physiologically predictive cancer invasion models.Invasive migration is a fundamental function underlying cellular processes such as angiogenesis, embryonic development, immune response, metastasis, and invasion of cancer cells. AMSBIO's new 3D Culture 96-Well BME Cell Invasion Assay offers a flexible, standardized, high-throughput...

Researchers respond enthusiastically to alvetex 3D cell culture

AMS Biotechnology (AMSBIO)

13/12/2012

AMSBIO’s customers are among those who are providing positive feedback on how the alvetex® 3D cell culture scaffold is opening up much more relevancy in their applications. These comments* come from a variety of scientists both in industry and academia. Available in a range of flexible, easy-to-use formats - alvetex® is proven to be fully compatible with a wide range of assays including tissue processing, histological staining, in situ hybridization,...

Qualified Human Feeder Cells for iPSC Reprogramming

AMS Biotechnology (AMSBIO)

29/11/2012

AMSBIO has announced the launch of Newborn Human Foreskin Fibroblasts qualified for induced Pluripotent Stem Cell (iPSC)* reprogramming.During cellular reprogramming the feeder layer can greatly affect the health of the cell culture and the success of the reprogramming. While a range of inactivated fibroblasts can be used as a support layer for pluripotent cell culture, not all will support mRNA reprogramming. Newborn Human Foreskin Fibroblasts (NuFF-RQ™) have been...

RNA Sequencing Kits Improve NGS Workflow

AMS Biotechnology (AMSBIO)

20/11/2012

AMSBIO small RNA and mRNA sample library construction kits have been designed to enable fast and cost-effective Next-Generation Sequencing (NGS)As a disruptive technology, NGS is rapidly changing the landscape of biomarker research, clinical diagnostics, and drug development. NGS technologies include a number of methods that are grouped broadly as template preparation, sequencing and imaging, and data analysis. The unique combination of specific protocols distinguishes one...

Comprehensive range of ready-to-use RNAs

AMS Biotechnology (AMSBIO)

24/10/2012

AMSBIO has expanded its range of ready-to-use RNA samples to now include mRNA / microRNA tissue preparations and a large number of RNAs from mouse and rat development stages.With more than 20 years of experience in RNA isolation, AMSBIO has generated over 4000 individual total RNAs ready to go off-the-shelf, many with bioanalyser RIN scores to demonstrate their high quality. Isolated from a variety of tissues - the AMSBIO biorepository of RNA samples covers over 30 species...